Minoxidil to SALT
Preview text: Reviews from men that made the switch.
No image available for this email.
- Subject
- Minoxidil to SALT
- Preview text
- Reviews from men that made the switch.
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Sat Jun 20, 2026, 7:30 AM ET
- Size
- 49 KB
- Images
- 12
- Links
- 14, 1 of them buttons
- Subject length
- 17 characters
Against Salt Grooming's usual
Sent in the 7 AM hour, which holds 3% of its emails; 19% arrive in the 5 AM hour. The subject is 17 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- SALT <[email protected]>
- Subject
- Minoxidil to SALT
- Date
- Sat, 20 Jun 2026 11:30:23 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-87
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from o1356.shared.klaviyomail.com [167.89.1.244] by our receiving server with ESMTPS
- by recvd-…-c4fkf with SMTP
- from (unnamed) by geopod-ismtpd-87 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| Jun 26, 2026 7:00 AM | Time zone change? | |
| Jun 24, 2026 3:01 PM | Build your SALT system. | |
| Jun 22, 2026 5:00 AM | Summer dries your hair out. Here's the fix. | |
| Jun 20, 2026 7:30 AM | Minoxidil to SALT (this email) | |
| Jun 18, 2026 5:30 AM | Humidity rising? You need this… | |
| Jun 14, 2026 2:00 PM | Introducing: The System Builder [Up to 20% off] | |
| Jun 12, 2026 5:00 AM | NEW: Hair Prescription Tool, now live. |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM







